Use of anxiolytic or hypnotic drugs and total mortality in a general middle‐aged population
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Purpose: The aim of the study was to evaluate the effect of the consumption of anxiolytic or hypnotic drugs on total mortality in a general population. Methods: We followed a cohort of 7225 men and 7726 women aged 40–42 years who underwent health surveys in 1985–1989 in two Norwegian counties, with respect to deaths. Mean follow‐up period was 18 years. The subjects were categorised according to frequency of anxiolytic or hypnotic drug use during the last month: daily, every week, less than every week and not used during the last month. Results: The proportion of anxiolytic or hypnotic drug users was 6.6% among men and 16.2% among women. Altogether 402 men and 290 women died. There was an increase in risk of death with an increase in frequency of use. Crude hazard ratios for men and women daily using anxiolytics or hypnotics were 3.1 (95%CI 2.0, 4.8) and 2.7 (1.9, 4.0), respectively, as compared with non‐users last month. After adjusting painkiller use and smoking the hazard ratios were lowered, being 2.4 (1.5–4.0) (men) and 2.1 (1.4–3.2) (women). After additional adjustments for other possible confounders the hazard ratios were further attenuated to 1.5 (0.9–2.7) for men and 1.7 (1.1–2.6) for women. Conclusions: Daily users of anxiolytic or hypnotic drugs in our study showed higher crude mortality than non‐users. However, after adjusting lifestyle and socio‐economic variables the difference was markedly reduced suggesting that the remaining excess mortality is due to residual confounding. Copyright © 2007 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepines with different half-life and falling in a hospitalized population
Passaro, A., Volpato, S., Romagnoni, F., Manzoli, N., Zuliani, G., & Fellin, R. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00254-7 · Cited by 122
Risk of suicide attempts after benzodiazepine and/or antidepressant use
Neutel, C. I., & Patten, S. B. (1997) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00126-9 · Cited by 88
Cited by
Weich, S., Pearce, H. L., Croft, P., Singh, S., Crome, I., Bashford, J., & Frisher, M. (2014) · BMJ · doi:10.1136/bmj.g1996 · Cited by 259
Polypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia
Tiihonen, J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1532 · Cited by 253
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Baandrup, L., Ebdrup, B. H., Rasmussen, J. Ø., Lindschou, J., Gluud, C., & Glenthøj, B. Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011481.pub2 · Cited by 128
A systematic review of research examining benzodiazepine-related mortality
Charlson, F., Degenhardt, L., McLaren, J., Hall, W., & Lynskey, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1694 · Cited by 107
“However, after adjustment for confounding effects of use of other substances the relationship held (OR¼ 2.86, 95%CI¼ 1.32–6.16).54 In 1998, Kripke et al.4 showed an association between prescription sleeping pill use and an increased risk of death within 6 years.”
BackgroundResultInfluentialBelleville, G. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500904 · Cited by 100
Metadata
- Authors
- Hausken, A. M., Skurtveit, S., & Tverdal, A.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2007-05-08
- Volume
- 16
- Issue
- 8
- Pages
- 913-918
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2092031580
- Cited by
- 53
- References
- 2
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.